Cytochrome P450 2E1: Its clinical and toxicological role

Journal of Clinical Pharmacy and Therapeutics

Volumn 25, Issue 3, 2000, Pages 165-175

  Tanaka, E ^a   Terada, M ^a,b   Misawa, S ^a  

^a UNIVERSITY OF TSUKUBA   (Japan)

^b OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ALCOHOL; ANALGESIC AGENT; ANESTHETIC AGENT; ANTICONVULSIVE AGENT; ANTIDEPRESSANT AGENT; ANTIINFECTIVE AGENT; BRONCHODILATING AGENT; CAFFEINE; CARCINOGEN; CENTRAL STIMULANT AGENT; CHLORZOXAZONE; DIMETHYLNITROSAMINE DEMETHYLASE; DRUG METABOLIZING ENZYME; ENFLURANE; FELBAMATE; FLUOXETINE; HALOTHANE; ISOFLURANE; MUSCLE RELAXANT AGENT; PARACETAMOL; PHENOBARBITAL; SEVOFLURANE; SULFADIAZINE; THEOPHYLLINE; TRIMETHADIONE; XENOBIOTIC AGENT;

DRUG METABOLISM; ENZYME ACTIVITY; ENZYME POLYMORPHISM; HUMAN; LIVER METABOLISM; REVIEW; XENOBIOTIC METABOLISM;

ANESTHETICS; ANIMALS; CHLORZOXAZONE; CYTOCHROME P-450 CYP2E1; ETHANOL; HUMANS; ISOENZYMES; NOXAE; SUBSTRATE SPECIFICITY; TRIMETHADIONE;

EID: 0033916349     PISSN: 02694727     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2710.2000.00282.x     Document Type: Review

References (99)

1. 1. Koop DR. (1992) Oxidative and reductive metabolism by cytochrome P450 2E1. FASEB Journal, 6, 724-730.
2. 2. Johansson I, Eliasson E, Norsten C, Ingelman-Sundberg M. (1986) Hydroxylation of acetone by ethanol-and acetone-inducible cytochrome P-450 in liver microsomes and reconstituted membranes. FEBS Letter, 196, 59-64.
3. 3. Nakajima T, Elovaara E, Park SS, Gelboin HV, Hietanen E, Vainio H. (1989) Immunochemical characterization of cytochrome P-450 isozymes responsible for benzene oxidation in the rat liver. Carcinogenesis, 10, 1713-1717.
4. 4. Raucy JL, Kraner JC, Lasker JM. (1993) Bioactivation of halogenated hydrocarbons by cytochrome P4502E1. Critical Review of Toxicology, 23, 1-20.
5. 5. Nakajima T. (1997) Cytochrome isoforms and the metabolism of volatile hydrocarbons of low relative molecular mass. Journal of Occupational Health, 39, 83-91.
6. 6. Kharasch ED. (1995) Biotransformation of sevoflurane. Anesthesia and Analgesia, 81(Suppl.), S27-S38.
7. 7. Garton KJ, Yuen P, Meinwald J, Thummel KE, Kharasch ED. (1995) Stereoselective metabolism of enflurane by human liver cytochrome P450 2E1. Drug Metabolism and Disposition, 23, 1426-1430.
8. 8. Kharasch ED, Thummel KE. (1993) Identification of cytochrome P450 2E1 as the predominant enzyme catalyzing human liver microsomal defluorination of sevoflurane, isoflurane, and methoxyflurane. Anesthesiology, 79, 795-807.
9. 9. Holownia A, Mapoles J, Menez JF, Braszko JJ. (1997) Acetaminophen metabolism and cytotoxicity in PC12 cells transfected with cytochrome P4502E1. Journal of Molecular Medicine, 75, 522-527.
10. 10. Peter R, Bocker R, Beaune PH, Iwasaki M, Guengerich FP, Yang CS. (1990) Hydroxylation of chlorzoxazone as a specific probe for human liver cytochrome P-450IIE1. Chemical Research in Toxicology, 3, 566-573.
11. 11. Vesell ES, Seaton TD, A-Rahim YI. (1995) Studies on interindividual variations of CYP2E1 using chlorzoxazone as an in vivo probe. Pharmacogenetics, 5, 53-57.
12. 12. Bachmann K, Sarver JG. (1996) Chlorzoxazone as a single sample probe of hepatic CYP2E1 activity in humans. Pharmacology, 52, 169-177.
13. 13. Lieber CS. (1997) Cytochrome P-4502E1: its physiological and pathological role. Annual Review of Physiology, 77, 517-544.
14. 14. Tanaka E, Funae Y. (1996) Trimethadione: metabolism and assessment of hepatic drug-oxidizing capacity. Methods in Enzymology, 272, 163-169.
15. 15. Lucas D, Farez C, Bardou LG, Vaisse J, Attali JR, Valensi P. (1998) Cytochrome P450 2E1 activity in diabetic and obese patients as assessed by chlorzoxazone hydroxylation. Fundamental and Clinical Pharmacology, 12, 553-558.
16. 16. Mandl J, Banhegyi G, Kalapos MP, Garzo T. (1995) Increased oxidation and decreased conjugation of drugs in the liver caused by starvation. Altered metabolism of certain aromatic compounds and acetone. Chemico-Biological Interactions, 96, 87-101.
17. 17. McCarver DG, Byun R, Hines RN, Hichme M, Wegenek W. (1998) A genetic polymorphism in the regulatory sequences of human CYP2E1: association with increased chlorzoxazone hydroxylation in the presence of obesity and ethanol intake. Toxicology and Applied Pharmacology, 152, 276-281.
18. 18. Ronis MJJ, Lindros KO, Ingelman-Sundberg M. (1996) The CYP2E1 subfamily. In: Ioannides C, ed. Cytochromes P450: Methods and Toxicology Aspects. London: CRC Press, 211-239.
19. 19. Spracklin DK, Hankins DC, Fisher JM, Thummel KE, Kharasch ED. (1997) Cytochrome P450 2E1 is the principal catalyst of human oxidative halothane metabolism in vitro. Journal of Pharmacology and Experimental Therapeutics, 281, 400-411.
20. 20. Knight TL, Scatchard KM, Van Pelt FN, Kenna JG. (1994) Sera from patients with halothane hepatitis contain antibodies to halothane-induced liver antigens which are not detectable by immunoblotting. Journal of Pharmacology and Experimental Therapeutics, 270, 1325-1333.
21. 21. Kitteringham NR, Kenna JG, Park BK. (1995) Detection of autoantibodies directed against human hepatic endoplasmic reticulum in sera from patients with halothane-associated hepatitis. British Journal of Clinical Pharmacology, 40, 379-386.
22. 22. Eliasson E, Kenna JG. (1996) Cytochrome P450 2E1 is a cell surface autoantigen in halothane hepatitis. Molecular Pharmacology, 50, 573-582.
23. 23. Bourdi M, Chen W, Peter RM, et al. (1996) Human cytochrome P450 2E1 is a major autoantigen associated with halothane hepatitis. Chemical Research in Toxicology, 9, 1159-1166.
24. 24. Kharasch ED, Hankins D, Mautz D, Thummel KE. (1996) Identification of the enzyme responsible for oxidative halothane metabolism: implications for prevention of halothane hepatitis. Lancet, 347, 1367-1371.
25. 25. Njoku D, Laster MJ, Gong DH, Eger EI 2nd, Reed GF, Martin JL. (1997) Biotransformation of halothane, enflurane, isoflurane, and desflurane to trifluoroacetylated liver proteins: association between protein acylation and hepatic injury. Anesthesia and Analgesia, 84, 173-178.
26. 26. Eliasson E, Gardner I, Hume-Smith H, de Waziers I, Beaune P, Kenna JG. (1998) Interindividual variability in P450-dependent generation of neoantigens in halothane hepatitis. Chemico-Biological Interactions, 116, 123-141.
27. 27. Wandel C, Neff S, Keppler G, et al. (1997) The relationship between cytochrome P4502E1 activity and plasma fluoride levels after sevoflurane anesthesia in humans. Anesthesia and Analgesia, 85, 924-930.
28. 28. Ono S, Hatanak T, Hotta H, Tsutumi M, Satoh T, Gonzalez FJ. (1995) Chlorzoxazone is metabolized by human CYP1A2 as well by human CYP2E1. Pharmacogenrtics, 5, 143-150.
29. 29. Jayyosi Z, Knoble D, Muc M, Erick J, Thomas PE, Kelley M. (1995) Cytochrome P-450 2E1 is not the sole catalyst of chlorzoxazone hydroxylation in rat liver microsomes. Journal of Pharmacology and Experimental Therapeutics, 273, 1156-1161.
30. 30. Nedelcheva V. (1996) Effects of acetone on the capacity of o-xylene and toluene to induce several forms of cytochrome P450 in rat liver. Central European Journal of Public Health, 4, 119-122.
31. 31. Ernstgard L, Gullstrand E, Johanson G, Lof A. (1999) Toxicokinetic interactions between orally ingested chlorzoxazone and inhaled acetone or toluene in male volunteers. Toxicological Sciences, 48, 189-196.
32. 32. Dilger K, Metzler J, Bode JC, Klotz U. (1997) CYP2E1 activity in patients with alcoholic liver disease. Journal of Hepatology, 27, 1009-1014.
33. 33. Burckart GJ, Frye RF, Kelly P, et al. (1998) Induction of CYP2E1 activity in liver transplant patients as measured by chlorzoxazone 6-hydroxylation. Clinical Pharmacology and Therapeutics, 63, 296-302.
34. 34. Dupont I, Lucas D, Clot P, Menez C, Albano E. (1998) Cytochrome P4502E1 inducibility and hydroxyethyl radical formation among alcoholics. Journal of Hepatology, 28, 564-571.
35. 35. Mishin VM, Rosman AS, Basu P, Kessova I, Oneta CM, Lieber CS. (1998) Chlorzoxazone pharmacokinetics as a marker of hepatic cytochrome P4502E1 in humans. American Journal of Gastroenterology, 93, 2154-2161.
36. 36. Mizuno D, Tanaka E, Tanno K, Misawa S. (2000) Chlorzoxazone: a probe drug whose metabolism can be used to monitor toluene exposure in rats. Archives of Toxicology, in press.
37. 37. Kim RB, Yamazaki H, Chiba K, et al. (1996) In vivo and in vitro characterization of CYP2E1 activity in Japanese and Caucasians. Journal of Pharmacology and Experimental Therapeutics, 279, 4-11.
38. 38. Kurata N, Nishimura Y, Iwase M, et al. (1998) Trimethadione metabolism by human liver cytochrome P450: evidence for the involvement of CYP2E1. Xenobiotica, 28, 1041-1047.
39. 39. Tanaka E, Ishikawa A, Fukao K, et al. (1991) Trimethadione tolerance test for one-point estimation of the severity of liver damage in cirrhotic patients. International Journal of Clinical Pharmacology Therapy and Toxicology, 29, 333-336.
40. 40. Abei M, Tanaka E, Tanaka N, et al. (1995) Clinical significance of the trimethadione tolerance test in chronic hepatitis: a useful indicator of hepatic drug metabolizing capacity. Journal of Gastroenterology, 30, 478-484.
41. 41. Lieber CS. (1994) Mechanisms of ethanol-drug-nutrition interactions. Journal of Toxicology - Clinical Toxicology, 32, 631-681.
42. 42. Lieber CS. (1994) Susceptibility to alcohol-related liver injury. Alcohol and Alcoholism, (Suppl.2), 315-326.
43. 43. Kitson KE. (1996) Ethanol and acetaldehyde metabolism: past, present and future. Alcoholism, Clinical and Experimental Research, 20(Suppl.8), 82A-92A.
44. 44. Asai H, Imaoka S, Kuroki T, Monna T, Funae Y. (1996) Microsomal ethanol oxidizing system activity by human hepatic cytochrome P450s. Journal of Pharmacology and Experimental Therapeutics, 277, 1004-1009.
45. 45. Song BJ. (1996) Ethanol-inducible cytochrome P450 (CYP2E1): biochemistry, molecular biology and clinical relevance. 1996 up-date. Alcoholism, Clinical and Experimental Research, 20(Suppl.8), 138A-146A.
46. 46. Djordjevic D, Nikolic J, Stefanovic V. (1998) Ethanol interactions with other cytochrome P450 substrates including drugs, xenobiotics, and carcinogens. Pathologie Biologie (Paris), 46, 760-770.
47. 47. Lieber CS. (1988) Biochemical and molecular basis of alcohol-induced injury to liver and other tissues. New England Journal of Medicine, 319, 1639-1650.
48. 48. Lieber CS, Lasker JM, Alderman J, Leo MA. (1987) The microsomal ethanol oxidizing system and its interaction with other drugs, carcinogens, and vitamins. Annals of the New York Academy of Sciences, 492, 11-24.
49. 49. Naranjo CA, Bremner KE. (1993) Behavioural correlates of alcohol intoxication. Addiction, 88, 25-35.
50. 50. Paille F, Pissochet P, Pirollet P. (1993) Acute alcoholic intoxication and drugs. Revue du Praticien, 43, 2075-2080 (in French).
51. 51. Tanaka E, Misawa S. (1998) Pharmacokinetic interactions between acute alcohol ingestion and single doses of benzodiazepines, and tricyclic and tetracyclic antidepressents - an update. Journal of Clinical Pharmacy and Therapeutics, 23, 331-336.
52. 52. Park KS, Sohn DH, Veech RL, Song BJ. (1993) Translational activation of ethanol-inducible cytochrome P450 (CYP2E1) by isoniazid. European Journal of Clinical Pharmacology, 248, 7-14.
53. 53. Ross AD, Varghese G, Oporto B, Carmichael FJ, Israel Y. (1995) Effect of propylthiouracil treatment on NADPH-cytochrome P450 reductase levels, oxygen consumption and hydroxyl radical formation in liver microsomes from rats fed ethanol or acetone chronically. Biochemical Pharmacology, 49, 979-989.
54. 54. Hu Y, Mishin V, Johansson I, et al. (1994) Chlormethiazole as an efficient inhibitor of cytochrome P450 2E1 expression in rat liver. Journal of Pharmacology and Experimental Therapeutics, 269, 1286-1291.
55. 55. Jaya DS, Augstine J, Menon VP. (1993) Role of lipid peroxides, glutathione and antiperoxidative enzymes in alcohol and drug toxicity. Indian Journal of Experimental Biology, 31, 453-459.
56. 56. Emby DJ, Fraser BN. (1977) Hepatotoxicity of paracetamol enhanced by ingestion of alcohol: report of two cases. South African Medical Journal, 51, 208-209.
57. 57. Kamiyama T, Sato C, Liu J, Tajiri K, Miyakawa H, Marumo F. (1993) Role of lipid peroxidation in acetaminophen-induced hepatotoxicity: comparison with carbon tetrachloride. Toxicology Letters, 66, 7-12.
58. 58. Carroccio A, Wu D, Cederbaum AI. (1994) Ethanol increases content and activity of human cytochrome P4502E1 in a transduced HepG2 cell line. Biochemical and Biophysical Research Communications, 203, 727-733.
59. 59. Mitchell JR, Jollow DJ, Potter WZ, Davis DC, Gillette JR, Brodie BB. (1973) Acetaminophen-induced hepatic necrosis. I. Role of drug metabolism. Journal of Pharmacology and Experimental Therapeutics, 187, 185-194.
60. 60. Miners JO, Attwood J, Birkett DJ. (1984) Determinants of acetaminophen metabolism: effect of inducers and inhibitors of drug metabolism on acetaminophen's metabolic pathways. Clinical Pharmacology and Therapeutics, 35, 480-486.
61. 61. Critchley JA, Nimmo GR, Gregson CA, Woolhouse NM, Prescott LF. (1986) Inter-subject and ethnic differences in paracetamol metabolism. British Journal of Clinical Pharmacology, 22, 649-657.
62. 62. Patten CJ, Thomas PE, Guy RL, et al. (1993) Cytochrome P450 enzymes involved in acetaminophen activation by rat and human liver microsomes and their kinetics. Chemical Research in Toxicology, 6, 511-518.
63. 63. Dai Y, Cederbaum AI. (1995) Cytotoxicity of acetaminophen in human cytochrome P4502E1-transfected HepG2 cells. Journal of Pharmacology and Experimental Therapeutics, 273, 1497-1505.
64. 64. Ward SJ. (1997) Paracetamol hepatotoxicity. Journal of the Royal Society of Medicine, 90, 527-528.
65. 65. Farrell GC. (1997) Drug-induced hepatic injury. Journal of Gastroenterology and Hepatology, 12, S242-S250.
66. 66. Corcoran GB, Mitchell JR, Vaishnav YN, Horning EC. (1980) Evidence that acetaminophen and N-hydroxyacetaminophen form a common arylating intermediate, N-acetyl-, p-benzoquinoneimine. Molecular Pharmacology, 18, 536-542.
67. 67. McKinnon RA, Nebert DW. (1998) Cytochrome P450 knockout mice: new toxicological models. Clinical and Experimental Pharmacology and Physiology, 25, 783-787.
68. 68. Gonzalez FJ. (1998) The study of xenobiotic-metabolizing enzymes and their role in toxicity in vivo using targeted gene disruption. Toxicological Letters, 102-103, 161-166.
69. 69. Lee SS, Buters JT, Pineau T, Fernandez-Salguero P, Gonzalez FJ. (1996) Role of CYP2E1 in the hepatotoxicity of acetaminophen. Journal of Biological Chemistry, 271, 12063-12067.
70. 70. Zaher H, Buters JT, Ward JM, et al. (1998) Protection against acetaminophen toxicity in CYP1A2 and CYP2E1 double-null mice. Toxicology Applied Pharmacology, 152, 193-199.
71. 71. Wang RS, Nakajima T, Tsuruta H, Honma T. (1996) Effect of exposure to four organic solvents on hepatic cytochrome P450 isozymes in rat. Chemico-Biological Interactions, 99, 239-252.
72. 72. Nakajima T, Wang RS. (1994) Induction of cytochrome P450 by toluene. International Journal of Biochemistry, 26, 1333-1340.
73. 73. Kim H, Wang RS, Elovaara E, et al. (1997) Cytochrome P450 isozymes responsible for the metabolism of toluene and styrene in human liver microsomes. Xenobiotica, 27, 657-665.
74. 74. Nakajima T, Wang RS, Elovaara E, et al. (1997) Toluene metabolism by cDNA-expressed human hepatic cytochrome P450. Biochemical Pharmacology, 53, 271-277.
75. 75. Pyykkö K. (1983) Age-and sex-related differences in rat liver microsomal enzymes and their inducibility by toluene. Acta Pharmacology and Toxicology, 53, 401-409.
76. 76. Pyykkö K. (1983) Time course of effects of toluene, on microsomal enzymes in rat liver, kidney and lung during and after inhalation exposure. Chemico-Biological Interactions, 44, 299-310.
77. 77. Nakajima T, Elovaara E, Okino T, et al. (1995) Different contributions of cytochrome P450 2E1 and P450 2B1/2 to chloroform hepatotoxicity in rat. Toxicology Applied Pharmacology, 133, 215-222.
78. 78. Lipscomb JC, Garrett CM, Snawder JE. (1997) Cytochrome P450-dependent metabolism of trichloroethylene: interindividual differences in humans. Toxicology Applied Pharmacology, 142, 311-318.
79. 79. Griffin JM, Lipscomb JC, Pumford NR. (1998) Covalent binding of trichloroethylene to proteins in human and rat hepatocytes. Toxicology Letters, 95, 173-181.
80. 80. Yin H, Anders MW, Jones JP. (1996) Metabolism of 1,2-dichloro-1-fluoroethane and 1-fluoro-1,2,2-trichloroethane: electronic factors govern the regioselectivity of cytochrome P450-dependent oxidation. Chemical Research in Toxicology, 9, 50-57.
81. 81. Leavens TL, Farris GM, James RA, et al. (1997) Genotoxicity and cytotoxicity in male B6C3F1 mice following exposure to mixtures of 1,3-butadiene and styrene. Environmental and Molecular Mutagenesis, 29, 335-345.
82. 82. Kim SK, Kim YC. (1996) Effect of a single administration of benzene, toluene or m-xylene on carboxyhaemoglobin elevation and metabolism of dichloromethane in rats. Journal of Applied Toxicology, 16, 437-444.
83. 83. Miyata M, Kudo G, Lee YH, et al. (1999) Targeted disruption of the microsomal epoxide hydrolase gene. Microsomal epoxide hydrolase is required for the carcinogenic activity of 7,12-dimethylbenz[a]anthracene. Journal of Biological Chemistry, 274, 23963-23968.
84. 84. Itoh K, Chiba T, Takahashi S, et al. (1997) An Nrf2/small Maf heterodimer mediates the induction of phase II detoxifying enzyme genes through antioxidant response elements. Biochemical and Biophysical Research Communications, 236, 313-322.
85. 85. Constan AA, Sprankle CS, Peters JM, et al. (1999) Metabolism of chloroform by cytochrome P450 2E1 is required for induction of toxicity in the liver, kidney, and nose of male mice. Toxicology Applied Pharmacology, 160, 120-126.
86. 86. Bondoc FY, Bao Z, Hu WY, et al. (1999) Acetone catabolism by cytochrome P450 2E1: studies with CYP2E1-null mice. Biochemical Pharmacology, 58, 461-463.
87. 87. Hong JY, Wang YY, Bondoc FY, et al. (1999) Metabolism of methyl tert-butyl ether and other gasoline ethers in mouse liver microsomes lacking cytochrome P450 2E1. Toxicological Letters, 105, 83-88.
88. 88. Lin HL, Parsels LA, Maybaum J, Hollenberg PF. (1999) N-Nitrosodimethylamine-mediated cytotoxicity in a cell line expressing P450 2E1: evidence for apoptotic cell death. Toxicology Applied Pharmacology, 157, 117-124.
89. 89. Bastien MC, Villeneuve JP. (1998) Characterization of cytochrome P450 2E1 activity by the [14C]nitrosodimethylamine breath test. Canadian Journal of Physiology and Pharmacology, 76, 756-763.
90. 90. Wong FW, Chan WY, Lee SS. (1998) Resistance to carbon tetrachloride-induced hepatotoxicity in mice which lack CYP2E1 expression. Toxicology Applied Pharmacology, 153, 109-118.
91. 91. Shimada T, Yamazaki H, Mimura M, Inui Y, Guengerich FP. (1994) Interindividual variation in human liver cytochrome P-450 enzymes involved in the oxidation of drugs, carcinogens and toxic chemicals: studies with liver microsomes of 30 Japanese and 30 Caucasians. Journal of Pharmacology and Experimental Therapeutics, 270, 414-423.
92. 92. Kwak MK, Kim SG, Kwak JY, Novak RF, Kim ND. (1994) Inhibition of cytochrome P4502E1 expression by organosulfur compounds allylsulfide, allylmercaptan and allylmethylsulfide in rats. Biochemical Pharmacology, 47, 531-539.
93. 93. O'Shea D, Davis SN, Kim RB, Wilkinson GR. (1994) Effect of fasting and obesity in humans on the 6-hydroxylation of chlorzoxazone: a putative probe of CYP2E1 activity. Clinical Pharmacology and Therapeutics, 56, 359-367.
94. 94. Rendic S, Di Carlo FJ. (1997) Human cytochrome P450 enzymes: a status report summarizing their reactions, substrates, inducers, and inhibitors. Drug Metabolism Review, 29, 413-580.
95. 95. Pelkonen O, Maenpaa J, Taavitsainen P, Rautio A, Raunio H. (1998) Inhibition and induction of human cytochrome P450 (CYP) enzymes. Xenobiotica, 28, 1203-1253.
96. 96. Wrighton SA, Thomas PE, Molowa DT, et al. (1986) Characterization of ethanol-inducible human liver N-nitrosodimethylamine demethylase. Biochemistry, 25, 6731-6735.
97. 97. Wrighton SA, Stevens JC. (1992) The human hepatic cytochromes P450 involved in drug metabolism. Critical Review of Toxicology, 22, 1-21.
98. 98. Morel G, Cossec B, Lambert AM, Binet S. (1999) Evaluation of rat hepatic 2E1 activity in function of age, sex and inducers: choice of an experimental model capable of testing the hepatotoxicity of low molecular weight compounds. Toxicological Letters, 106, 171-180.
99. 99. Nakajima T. (1998) Methods of study on cytochrome P450 in relation to the metabolism and toxicity of alcohol and drugs. Japanese Journal of Alcohol and Drug Dependence, 33, 210-218 (in Japanese with English summary).